Landscape Capital Management’s Lipocine LPCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,480
Closed -$170K 530
2017
Q2
$170K Buy
2,480
+33
+1% +$2.15K 0.02% 294
2017
Q1
$162K Buy
+2,447
New +$159K 0.02% 467
2016
Q3
Sell
-1,702
Closed -$88K 531
2016
Q2
$88K Sell
1,702
-527
-24% -$81.6K 0.01% 517
2016
Q1
$385K Buy
+2,229
New +$380K 0.05% 425

Other funds holding LPCN

Landscape Capital Management's LPCN Position: Q3 2017 in Review

Landscape Capital Management sold out of Lipocine (LPCN) in Q3 2017, closing a stake of 2,480 shares — an estimated $170K sold.

Landscape Capital Management first reported a position in LPCN in Q1 2016 and held it in 4 quarters. The position peaked at $385K in Q1 2016. 37 funds tracked by Wall St. Rank hold LPCN as of Q3 2017.

  • Landscape Capital Management reported no remaining Lipocine position as of Q3 2017 after selling out during the quarter.
  • Landscape Capital Management sold 2,480 Lipocine shares in Q3 2017, an estimated $170K.
  • Landscape Capital Management first reported a position in Lipocine in Q1 2016 and held it in 4 quarters.
  • Landscape Capital Management's Lipocine position peaked at $385K in Q1 2016.
  • 37 funds tracked by Wall St. Rank held Lipocine as of Q3 2017.

Based on Landscape Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.